Gut microbiota trigger influenced by tyrosine kinase inhibitors in mice

Gut microbial dysbiosis has been found in patients undergoing tyrosine kinase inhibitors treatment. To investigate whether the gut microbiota is altered by oral anlotinib administration, 16S rRNA sequencing was performed on intestinal contents from mice.